Another thing to note is rapid tests have a false positive rate of 1-2%. With the current COVID infection prevalence between 0.2% and 0.3% in the US, that means 84-89% of positives will be false positives. If you scale this by close to a million travelers per day, that's a lot of false positives. A lot of healthy people who won't make their meeting, or won't make their commute, and will definitely be out the cost of their ticket. That would be enough for me to chose driving or flying a clapped out 172 instead, regardless of how convenient the process is made to be. That's why passenger numbers will fall drastically.
asm.org
Hopefully since the current administration "follows the syance" they will read these same papers and others like them to conclude that it is indeed a bad idea.
SARS-CoV-2 Testing: Sensitivity Is Not the Whole Story | ASM.org
Some have urged large-scale, frequent testing with lateral flow SARS-CoV-2 antigen tests to curb the COVID-19 pandemic, but factors like test specificity, cost and feasibility need to be considered.
Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests
Widespread COVID-19 testing is paramount for the receipt of timely medical care and for curtailing transmission. The USA continues to face formidable challenges in making testing accessible for all because efforts to scale up COVID-19 testing have fallen short.1 RT-PCR testing for severe acute...
www.thelancet.com
Hopefully since the current administration "follows the syance" they will read these same papers and others like them to conclude that it is indeed a bad idea.